Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I hope we get them Friday. He’s hitting the media circuit this week so who knows.
Was? Still have another 40 mins!!!
Agreed. The guy looked bullet proof. If he’s worried, he gets an Oscar nod for today’s action.
Earnings on Friday?
https://www.tipranks.com/stocks/hmny/earnings-calendar
No way, no how this puppy is done for the week.
Yep. That also sounds like Clay. Thanks for sharing.
Haha. I love it. I can’t fault you for that.
It was actually refreshing Clay wasn’t the typical RobotClay 2000.
Thanks for sharing, mr repeat what clay just said. Lol
Thank you very much for sharing.
What does a golden cross indicate. TIA.
Roger. Thanks.
Lazer, one follow up: how often do option prices change? For CRMD is there a need to buy any December or March options immediately?
So that I am clear, the filing about Jenny purchasing shares...that was a multiple of 100, correct? The CEO didn’t purchase just 100 shares, did she? Not $255 worth.
Thanks for the input. I have heard this warning from multiple people and you really have to say to yourself: where there is smoke, there’s likely fire.
If I jump in it will be in the hundreds, not thousands, of dollars. I’ve been around enough to know beginners luck is like any other luck: right place, right time, and sprinkled with a dash of the end-user’s perceived certainly.
In this instance, if someone perceives a buyout as a high probability, options make sense because it takes any possible MM manipulation out of the equation. Any BO offer over $2.50 and MM’s are powerless. At $.05 or $.10 per contract, the juice is worth the squeeze, IMO.
Having said the above, I’ll likely take a modest option position tomorrow in the hundred$).
Given the current events, there are several catalysts that could get across the $2.50 strike price by 19 March 2019.
Just don’t mortgage the house in the process; I hear you loud and clear.
And might I add, this has been a great dialogue this weekend. Thank you all for imparting your wisdom. So often on iHub it can get ugly. I am glad that has not been the case with CRMD.
December $2.50 options are more aggressive, but when I go to buy it says there are no purchasers?
Fantastic post! Between you and Lazer, I can’t thank you both enough. I think my confusion stemmed with the secondary option market, wasn’t sure how the mechanics worked-I am literally that much of a noob.
I might actually take a position at this point. The December options appear to be cheaper, but I think the safer option (pun intended) is March 2019. A few more events need to happen —submit to FDA, FDA 60 days for approval, etc., soon enough January 2019 arrives and BOOM, stick a fork in it.
Good to see another long on the thread! I’m going with my hunch on this one. I think we’re going to be winners in a big way.
Again, thank you (and Lazer).
Ha. I just realized you could sell the option for the profit without actually having to purchase the underlying shares. I think that’s right. :-0
I took a harder look and there isn’t much meat left on those $2.50 strike price options absent an unflinching belief that a buyout is going to happen.
And I’m not that confident.
By the by, if it hits the strike price, I understand the profit to be had is any amount over the $2.50 mark. In order to access that profit, I need to buy the underlying 500 shares, correct?
Let’s say I buy 1 contract, 500 shares @ $2.50 for March 19 at a cost of $10. A week before it expires it hits strike price and I wind up selling at $2.75. I understand the profit is $.25 (the data between strike and sell price) x 500 shares = $125. Take away the $10 for the initial contract price and the profit is $115.
When I exercise and sell, do I pay the amount of $1,250 to then receive the $1,375?
You see, I told you I don’t have very much experience with options, lol.
Thank you so much. Have a great weekend!
This has been helpful. Thanks again. Can you confirm the options are 10 per contract or 100 per contract?
And because you are seeing very little activity, that’s telling you there not much confidence in the price being hit? Or in NFL parlance, the odds appear to be 100/1?
I do agree March would likely be a more solid play—magic doesn’t happen overnight.
Have a nice evening!
I have to educate myself on the mechanics of options, but this is intriguing.
What are the current options? If someone were supremely confident in the direction CRMD, what are the options?
Got it. Thanks again for sharing you thoughts with me. In my opinion, at $.64 a share, this is trading for peanuts against future potential.
I think we’ll be proven right.
Thank you. I am notoriously patient with biotech—much to my chagrin with my most recent foray with DCTH. Let’s just leave that hot mess as a don’t ask don’t tell.
For a buyout to be considered in the realm of possibility by CRMD and Elliot, where do you think an offer needs to be sit? $100M, $200M, $500M, etc.
Thanks and I’ll stop with the questions!
My apologies, I was focused on only partnership or going it alone.
A buyout is the mega mother, I absolutely agree, given the FDA fast track status and the Safety report.
What would it take to get Elliot on board for that?
Fastest way to lose $400 bucks in a day? Buy this turd and realize it’s a cluster F a day too late.
Always sniffing for something like UOIP, but this is a catastrophe.
Even if they get a verdict for $200M (snicker snicker) which of those jokers has the capacity to pay? Sure there’s the Summons in Garnishment and filing liens in the defendants county courthouses against inheritance, etc., but if $200M was the end game and CMG is forced to those type of collection mechanisms, the game is already over.
In the end, just another OTC turd.
WAFJ.
I wonder if the CEO would want to go without a partnership. The level Of effort going ground up is a massive undertaking.
I see companies like Athenex routinely strike partnership deals. That would be the path of least resistance. Your thoughts?
So then a partnership, if it happens, would need Elliot’s blessing it sounds like.
Would that help or hinder a deal? On one hand, it may benefit us retail shareholders because their sole interest is maximizing profit. On the other hand, it could hurt us retail shareholders because their sole interest is maximizing profit.
That’s why the end game is partnership, IMO, and I think it’s going to happen in the next 2-6 months. I don’t see a reason why they don’t already have an agreement in principle with a partner.
It’s clear they’ve been looking for a partner for a while, and now with the data being as good as bulletproof, I think the plans have been set.
In the end, while Elliot is a baller, they only own 10% of the company. Do you think they have the muscle to prevent a partnership? I don’t know.
Wait, so next week isn’t a go?
Yeah, three hours in and I am already have reservations. :-0
What’s your thought on near term PPS? Near term being 1-3 months. TKS.
I just took out the .0044's. In w/585,000 shares.
Agree 100%. Parking money here near-term is a no brained for me.
GLTY.
Thanks for the detailed and thoughtful response. I heard back from IR. With respect to my questions about whether we’ll get a PR about FDA submission, he sent the link to the PR issued today and asked that I take note of the conference call starting at 4:30 when the CEO speaks on the 14th.
I expect that to be the next big update (unless partnership happens-lol), but not getting hopes! This baby is going to slow burn over the next few months into the multiple dollar range if the manner in which they deal with the FDA is as polished as those safety analysis reports!!!
GIDDY UP!
Sorry, Lazer, for the misspelling.
Lazier, sent email to IR. Curious if they plan on issuing PR to announce they have submitted the safety analysis along with DSMB’s recommendation to halt the remaining trial.
That would make a nice teaser going into earnings next week. More importantly, it starts the 60 day window for the FDA to respond.
Thoughts?
Shhhhhhh.
This is about as speculation-free as they come.
Clay is a fart ?? in the wind. Pay him no mind.
Talent trumps. CRMD at $3 before you know it.
Hahaha. That’s a funny one!